Open the door to a bright, clear future
The Advanced CustomVue™ procedure is ushering in a new era in laser vision correction. The doorway to freedom from glasses and contact lenses is now open to millions of people, including many who were once told they were not candidates. The reason is simple-until now, there has never been a laser vision correction procedure that offers the precision and accuracy of the Advanced CustomVue procedure. Since 2003, the Advanced CustomVue procedure has earned FDA approval to treat the broadest range of vision imperfections possible, including mild to severe nearsightedness (up to 11 diopters of correction), farsightedness, all types of astigmatism, and now loss of reading vision or presbyopia.
It is possible
Clinical studies presented to the FDA show that the Advanced CustomVue procedure can potentially produce better vision than is possible with glasses or contact lenses. In fact, clinical studies have shown that more patients were satisfied or very satisfied with their vision after the Advanced CustomVue treatment than they were before treatment with glasses or contact lenses.
The difference is clear
The results patients experience are made possible by remarkable technology advances and exclusive mathematical formulas that combine to create the Advanced CustomVue procedure. Technologies include the WaveScan WaveFront™ system that identifies and measures imperfections in a patient’s eyes 25 times more
precisely than standard measurements for glasses or contact lenses. The WaveScan® System transfers the digital data to the STAR S4 IR® Excimer Laser, which is used to perform the treatment.
In addition, the Advanced CustomVue procedure uses FDA-approved VISX® Iris Registration Technology, a non-contact method of aligning the treatment to the cornea, providing greater laser alignment accuracy.
First and foremost The Advanced CustomVue procedure was developed by VISX, the company that invented laser vision correction. VISX Technology remains the industry’s leader in the U.S., used by more doctors than all others combined. In 2005, VISX was acquired by Advanced Medical Optics, Inc., forming a global leader in vision care.
The path to freedom
Your journey begins by scheduling a personal consultation with Drs. Coad or Eviatar. During your visit, you’ll learn about the procedure and undergo testing that ensures you are a good candidate to receive Advanced CustomVue treatment. One of the tests you will undergo is a WaveScan System test which creates a map of the unique imperfections of your eyes. The Advanced CustomVue procedure uses the digital information from that map to design a custom treatment for each of your eyes.
VISX Iris Registration technology, available only with the Advanced CustomVue procedure, centers treatment correctly, independent of the normal pupil shift that occur after measurement and before treatment, regardless of the amount of time between. The one-of-a-kind approach and technical safeguards allow the Advanced CustomVue procedure to achieve exceptional accuracy and precision.
Full speed ahead
On the day of treatment, the doctor will place anesthetic drops in your eyes. The WaveScan map data is transferred to the STAR S4 IR Excimer Laser, which uses a cool laser beam to remove microscopic layers of cells, reshaping your cornea to create a new curvature.
Bringing your world into focus
Many patients experience immediate results, which continue to improve over the next several days. The morning following surgery, patients often wake up to a crisp, clear view of the world that surprises and delights them.
Looking ahead
During clinical trials for FDA approvals of all indications – nearsightedness, extreme nearsightedness, farsightedness, mixed astigmatism – participants treated were tested over many months.
Open the door to a world in focus
Take the next step by calling today to schedule your consultation. Step through the doorway and enter a new world without the hassles of glasses and contact lenses!
One year after treatments, results showed:
- More than 95 percent could pass a driving test without glasses or contact lenses.
- Almost three quarters could see 20/20 or better without glasses or contact lenses
- At six months, three times as many patients were very satisifed with their night vision after treatment compared to night vision before treatment with glasses or contact lenses.
Other notable outcomes for specific indications show:
- 98 percent of mild-to-moderate nearsighted patients could see 20/20 or better one year after treatment.
- 100 percent of extremely nearsighted patients and more than 95 percent of patients with mixed astigmatism could pass a driving test without glasses or contact lenses one year after treatment.
The procedure keeps getting better – Advanced CustomVue™ Monovision
Advanced CustomVue Monovision is the first FDA approved LASIK procedure allowed for the millions of nearsighted people who struggle with age-related presbyopia. Advanced CustomVue Monovision fills a gap in the treatment options available to presbyopic patients who do not want to wear reading glasses.
What is monovision?
- In monovision, the dominant eye is corrected for distance vision, and the other eye for near vision. The brain learns quickly to distinguish between the two; eventually the patient does not notice whicheye sees near and which eye sees far.
- Monovision correction is not new and is a frequently recommended choice by doctors for presbyopia. Until now, monovision was typically done using contact lenses or other procedures that provided temporary correction.
- By addressing both near and distance vision correction, the Advanced CustomVue Monovision LASIK procedure can reduce dependency on reading glasses and contact lenses; fulfilling the visual demands of today’s youthful, vibrant baby boomers with one of the safest, most advanced LASIK technologies available.
Advanced CustomVue Monovision Results
The FDA reviewed the excellent visual results delivered by the Advanced CustomVue Monovision procedure in a multi-center clinical trial*, involving 160 patients for up to two years. The data show: Six months after being treated with the Advanced CustomVue™ Monovision procedure:
- More than 96 percent of patients decreased their use of corrective lenses.
- 100 percent of patients achieved 20/40 or better vision at both distance and close up.
* Advanced CustomVue Procedure for Monovision Clinical Trial, 2006 submitted to the FDA
